###begin article-title 0
FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 824 831 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 980 984 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
FRAXE is a form of mild to moderate mental retardation due to the silencing of the FMR2 gene. The cellular function of FMR2 protein is presently unknown. By analogy with its homologue AF4, FMR2 was supposed to have a role in transcriptional regulation, but robust evidences supporting this hypothesis are lacking. We observed that FMR2 co-localizes with the splicing factor SC35 in nuclear speckles, the nuclear regions where splicing factors are concentrated, assembled and modified. Similarly to what was reported for splicing factors, blocking splicing or transcription leads to the accumulation of FMR2 in enlarged, rounded speckles. FMR2 is also localized in the nucleolus when splicing is blocked. We show here that FMR2 is able to specifically bind the G-quartet-forming RNA structure with high affinity. Remarkably, in vivo, in the presence of FMR2, the ESE action of the G-quartet situated in mRNA of an alternatively spliced exon of a minigene or of the putative target FMR1 appears reduced. Interestingly, FMR1 is silenced in the fragile X syndrome, another form of mental retardation. All together, our findings strongly suggest that FMR2 is an RNA-binding protein, which might be involved in alternative splicing regulation through an interaction with G-quartet RNA structure.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 245 273 245 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fragile Mental Retardation 2</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 677 680 677 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1 B2 B3">1&#8211;3</xref>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
Fragile X E (FRAXE) mental retardation (OMIM 309548) is associated to a fragile site localized in Xq28 and is the cause of a non-syndromic X-linked mental retardation affecting 1/50 000 newborn males. The disorder is due to the silencing of the Fragile Mental Retardation 2 (FMR2) gene, as a consequence of a CCG expansion located upstream to this gene. In the normal population, the number of this CCG repeat is variable between 6 and 35, while it is increased to more than 200 hyper-methylated copies in FRAXE mentally retarded patients. The CCG repeat of FRAXE can either expand or contract and is equally unstable when transmitted through the male or the female germ line (1-3).
###end p 4
###begin p 5
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr2</italic>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 916 917 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 920 924 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 960 963 960 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AF4</italic>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LAF4</italic>
###xml 975 976 975 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 982 988 982 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AF5q31</italic>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1170 1173 1170 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AF4</italic>
###xml 1357 1359 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1362 1365 1362 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AF4</italic>
###xml 1605 1607 1605 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1614 1618 1614 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 1656 1666 1656 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1672 1683 1672 1683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lilliputian</italic>
###xml 1685 1691 1685 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lilli)</italic>
###xml 1763 1768 1763 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lilli</italic>
###xml 1842 1853 1842 1853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">serendipity</italic>
###xml 1855 1867 1855 1867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fushi tarazu</italic>
###xml 1872 1881 1872 1881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">huckebein</italic>
###xml 1948 1950 1948 1950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
###xml 1429 1434 <span type="species:ncbi:10090">mouse</span>
###xml 1656 1666 <span type="species:ncbi:7227">Drosophila</span>
The FRAXE mental retardation is a form of mild to moderate mental retardation associated to learning difficulties, communication deficits, attention problems, hyperactivity and autistic behaviour (4). Fmr2 inactivation generated mice displaying a delay-dependent conditioned fear impairment and a hippocampal increased long-term potentiation (LTP) (5). FMR2 is a large gene with a major 8.75-kb transcript in placenta, fibroblasts adult and brain and a longer 13.7-kb FMR2 isoform in fetal brain (6). The FMR2 gene is organized in 22 exons, showing several possibilities of alternative splicing for exons 2, 3, 5, 7 and 21. The longest of the FMR2 isoforms is composed of 1272 amino acids and contains two nuclear localization signal (NLS) sequences that are both able to direct GFP into the nucleus (6). The nuclear localization of the endogenous FMR2 protein was also shown by immunohistochemistry in mouse brain (7). FMR2 belongs to a gene family including AF4 (8), LAF4 (9) and AF5q31 (10). These genes were originally cloned due to their fusion with MLL (mixed lineage leukaemia) in different chromosomal translocations causing acute lymphoblastic leukaemia (ALL). AF4 is the best characterized member of this family, appears to play a role in transcription, since it interacts with Polymerase II (Pol II) and with the chromatin remodelling machinery (11). AF4 deficient mice have an altered lymphoid development. Indeed in mouse, AF4 affects early events in lymphopoiesis, such as precursor proliferation or recruitment, but it is not required for the terminal stages of lymphocyte differentiation (12). The FMR2 gene family has a common ancestor in Drosophila: the Lilliputian (lilli) gene, whose inactivation generates flies of reduced size. In addition, lilli mutant flies show reduced expression of some early zygotic genes such as serendipity, fushi tarazu and huckebein, that are essential for cellularization and embryonic patterning (13).
###end p 5
###begin p 6
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 653 660 653 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 709 739 709 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fragile X Mental Retardation 1</italic>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
By analogy with AF4, FMR2 has been considered to be a putative transcription activator. However, it is important to underline that the ability of FMR2 to activate transcription was proven only for some domains, but not for the full-length protein (14). The purpose of this study was to unravel the function of FMR2 that is currently unknown. We show here that FMR2 is localized in SC35-containing nuclear speckles, being implicated in splicing. This role in splicing is carried out through its specific interaction with G-quartet RNA, a structure known to be able to act as an exonic splicing enhancer (ESE) (15). We also show here that FMR2 influences in vivo the alternative splicing pattern of the mRNA of Fragile X Mental Retardation 1 (FMR1), which contains a G-quartet nearby an acceptor site of the alternatively spliced exon 14 (16).
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Plasmids constructions
###end title 8
###begin p 9
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 127 134 127 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 574 581 574 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 634 642 634 642 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 642 721 642 721 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="10">Primers used to clone full-length <italic>FMR2</italic> and its deletion constructs in Flag-pTL1</p>
###xml 642 721 642 721 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="10">Primers used to clone full-length <italic>FMR2</italic> and its deletion constructs in Flag-pTL1</p></caption>
###xml 721 731 721 731 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Constructs</th>
###xml 731 758 731 758 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Forward and reverse primers</th>
###xml 721 758 721 758 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr>
###xml 721 758 721 758 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead>
###xml 758 769 758 769 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Full-length</td>
###xml 769 803 769 803 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td>
###xml 758 803 758 803 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Full-length</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr>
###xml 803 808 803 808 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N-ter</td>
###xml 808 842 808 842 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td>
###xml 803 842 803 842 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr>
###xml 842 842 842 842 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 842 876 842 876 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td>
###xml 842 876 842 876 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr>
###xml 876 876 876 876 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 876 911 876 911 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGGGATCCGGCTGGTTTGTGGGCAGTGGC-3&#8242;</td>
###xml 876 911 876 911 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGATCCGGCTGGTTTGTGGGCAGTGGC-3&#8242;</td></tr>
###xml 911 916 911 916 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">C-ter</td>
###xml 916 951 916 951 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td>
###xml 911 951 911 951 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr>
###xml 951 951 951 951 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 951 985 951 985 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td>
###xml 951 985 951 985 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr>
###xml 985 987 985 987 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">C1</td>
###xml 987 1022 987 1022 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td>
###xml 985 1022 985 1022 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">C1</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr>
###xml 1022 1022 1022 1022 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1022 1056 1022 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGGGGATCCCAGTGGTGGTGACAATGGC-3&#8242;</td>
###xml 1022 1056 1022 1056 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCAGTGGTGGTGACAATGGC-3&#8242;</td></tr>
###xml 758 1056 758 1056 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">Full-length</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGATCCGGCTGGTTTGTGGGCAGTGGC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C1</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCAGTGGTGGTGACAATGGC-3&#8242;</td></tr></tbody>
###xml 721 1056 721 1056 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Full-length</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGATCCGGCTGGTTTGTGGGCAGTGGC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C1</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCAGTGGTGGTGACAATGGC-3&#8242;</td></tr></tbody></table>
###xml 634 1056 634 1056 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="10">Primers used to clone full-length <italic>FMR2</italic> and its deletion constructs in Flag-pTL1</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Full-length</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGATCCGGCTGGTTTGTGGGCAGTGGC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCTACAACAAGTGGGCATCG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C1</td><td rowspan="1" colspan="1">5&#8242;-GGCTCGAGGCCACTGCCCACAAACCAGCC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GGGGGATCCCAGTGGTGGTGACAATGGC-3&#8242;</td></tr></tbody></table></table-wrap>
###xml 1056 1064 1056 1064 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2.</label>
###xml 1086 1090 1086 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 1064 1135 1064 1135 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="11">Primers used to clone <italic>FMR2</italic> and its deletion constructs in pet-151D Topo</p>
###xml 1064 1135 1064 1135 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="11">Primers used to clone <italic>FMR2</italic> and its deletion constructs in pet-151D Topo</p></caption>
###xml 1135 1145 1135 1145 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Constructs</th>
###xml 1145 1172 1145 1172 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Forward and reverse primers</th>
###xml 1135 1172 1135 1172 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr>
###xml 1135 1172 1135 1172 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead>
###xml 1172 1176 1172 1176 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FMR2</td>
###xml 1176 1207 1176 1207 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td>
###xml 1172 1207 1172 1207 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">FMR2</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr>
###xml 1207 1207 1207 1207 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1207 1235 1207 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td>
###xml 1207 1235 1207 1235 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr>
###xml 1235 1240 1235 1240 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">N-ter</td>
###xml 1240 1271 1240 1271 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td>
###xml 1235 1271 1235 1271 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr>
###xml 1271 1271 1271 1271 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1271 1297 1271 1297 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CTAGGCTGGTTTGTGGGCAG-3&#8242;</td>
###xml 1271 1297 1271 1297 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTAGGCTGGTTTGTGGGCAG-3&#8242;</td></tr>
###xml 1297 1302 1297 1302 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">C-ter</td>
###xml 1302 1331 1302 1331 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CACCGCCACTGCCCACAAACCAG-3&#8242;</td>
###xml 1297 1331 1297 1331 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-CACCGCCACTGCCCACAAACCAG-3&#8242;</td></tr>
###xml 1331 1331 1331 1331 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1331 1359 1331 1359 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td>
###xml 1331 1359 1331 1359 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr>
###xml 1172 1359 1172 1359 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">FMR2</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTAGGCTGGTTTGTGGGCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-CACCGCCACTGCCCACAAACCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr></tbody>
###xml 1135 1359 1135 1359 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">FMR2</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTAGGCTGGTTTGTGGGCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-CACCGCCACTGCCCACAAACCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr></tbody></table>
###xml 1056 1359 1056 1359 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2.</label><caption><p textid="11">Primers used to clone <italic>FMR2</italic> and its deletion constructs in pet-151D Topo</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Constructs</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">FMR2</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">N-ter</td><td rowspan="1" colspan="1">5&#8242;- CACCGATCTATTCGACTTTTTCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTAGGCTGGTTTGTGGGCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">C-ter</td><td rowspan="1" colspan="1">5&#8242;-CACCGCCACTGCCCACAAACCAG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CTACAACAAGTGGGCATCGATG-3&#8242;</td></tr></tbody></table></table-wrap>
Full-length FMR2 cDNA was amplified by RT-PCR from NG108 RNA using LA Taq (TaKaRa) and primers whose sequences are reported in Table 1 containing the XhoI and BamHI restriction sites. PCR fragments were digested with restriction enzymes and cloned into the Flag-pTL1 plasmid (17). Three regions of FMR2 (N-ter, C-ter, C1) were amplified from full-length gene and subcloned into Flag-pTL1 vector (17) using the same restriction enzymes. The full-length FMR2, N-ter and C-ter domains cloned in Flag-pTL1 were amplified by PCR using the primers whose sequences are reported in Table 2 and cloned in a pET-151D Topo plasmid (Invitrogen). Table 1.Primers used to clone full-length FMR2 and its deletion constructs in Flag-pTL1ConstructsForward and reverse primersFull-length5'-GGCTCGAGGATCTATTCGACTTTTTCAG-3'N-ter5'-GGGGGATCCCTACAACAAGTGGGCATCG-3'5'-GGCTCGAGGATCTATTCGACTTTTTCAG-3'5'-GGGGATCCGGCTGGTTTGTGGGCAGTGGC-3'C-ter5'-GGCTCGAGGCCACTGCCCACAAACCAGCC-3'5'-GGGGGATCCCTACAACAAGTGGGCATCG-3'C15'-GGCTCGAGGCCACTGCCCACAAACCAGCC-3'5'-GGGGGATCCCAGTGGTGGTGACAATGGC-3'Table 2.Primers used to clone FMR2 and its deletion constructs in pet-151D TopoConstructsForward and reverse primersFMR25'- CACCGATCTATTCGACTTTTTCAG-3'5'-CTACAACAAGTGGGCATCGATG-3'N-ter5'- CACCGATCTATTCGACTTTTTCAG-3'5'-CTAGGCTGGTTTGTGGGCAG-3'C-ter5'-CACCGCCACTGCCCACAAACCAG-3'5'-CTACAACAAGTGGGCATCGATG-3'
###end p 9
###begin p 10
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
Primers used to clone full-length FMR2 and its deletion constructs in Flag-pTL1
###end p 10
###begin p 11
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
Primers used to clone FMR2 and its deletion constructs in pet-151D Topo
###end p 11
###begin p 12
###xml 107 109 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 412 414 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
The FBS and FBSDelta35 fragments were amplified from pTL1-N19 and pTL1-N19 Delta35 plasmids, respectively (18) using the following primers: 5'-GGGTCGACGAAGAGAGGGAGAGCTTC-3' (forward) and 5'-GGGGATCCGTTTCCTTTGAAGCCTCCTC-3' (reverse). The primers contain the SalI and BamHI restriction sites, respectively. The PCR fragments generated using these primers were digested and subcloned either in the SXN 13 minigene (19) or in the pGEM-T easy vector (Promega). All plasmids were verified by sequencing.
###end p 12
###begin title 13
Antibodies, immunofluorescence and immunoblot
###end title 13
###begin p 14
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
###xml 192 199 <span type="species:ncbi:9986">rabbits</span>
To generate the polyclonal anti-FMR2 antibody, a synthetic peptide-CPEQKNRMIPSHQETTHSS-corresponding to amino acids 116-133 of mouse FMR2 was coupled to ovalbumin and used for immunization of rabbits by standard protocols (Eurogentec). The characterization of this antibody is described in . The antiserum was affinity purified as described previously (20).
###end p 14
###begin p 15
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 343 349 <span type="species:ncbi:9986">rabbit</span>
###xml 373 377 <span type="species:ncbi:9925">goat</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
Transfection and immunofluorescence were carried out as previously described (20) using the following antibodies: polyclonal anti-FMR2 at 1:1000 (this study), monoclonal anti-Flag M2 (Sigma) at 1:1000, polyclonal anti-Flag (Sigma) at 1:1000, monoclonal anti-SC35 (Abcam) at 1:2000, and the following secondary antibodies: Alexa fluor 488 anti-rabbit IgG or Alexa fluor 594 goat anti-mouse IgG (Molecular Probes). Immunoblot was carried out as described (20) using polyoclonal anti-FMR2 (1:1000) (this study), monoclonal anti-Flag M2 (1:3000) (Sigma).
###end p 15
###begin title 16
Cell culture
###end title 16
###begin p 17
###xml 71 77 <span type="species:ncbi:9913">bovine</span>
###xml 124 129 <span type="species:ncbi:9606">Human</span>
###xml 194 200 <span type="species:ncbi:9913">bovine</span>
HeLa and NG108 cells were cultured in DMEM supplemented with 10% fetal bovine serum and 100 mug/ml penicillin/streptomycin. Human fibroblasts were grown in RPMI 1640 supplemented with 10% fetal bovine serum and 100 mug/ml penicillin/streptomycin.
###end p 17
###begin title 18
Actinomycin D treatment, microinjection
###end title 18
###begin p 19
###xml 217 219 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
NG108 and HeLa cells were incubated with Actinomycin D (ActD) (Sigma) at the final concentration of 5 mug/ml. Cytoplasmic microinjection of an antisense U6 oligonucleotide in SK-N-SH cells was performed as described (21) using lysine-fixable Cascade blue-conjugated dextran (Invitrogen) as a marker to identify injected cells. Cells were fixed 2 h after injection or 2-4 h after ActD treatment.
###end p 19
###begin title 20
Production and purification of recombinant proteins
###end title 20
###begin p 21
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 291 307 291 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 453 454 449 450 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 291 312 <span type="species:ncbi:511693">Escherichia coli BL21</span>
The FMR2 full length, N-ter and C-ter regions of FMR2 were amplified by PCR from its cDNA using the primers listed in Table 2. After purification, the PCR fragments were cloned in a pET-151D Topo plasmid (Invitrogen) as fusion proteins with a six histidine tag. The clones were expressed in Escherichia coli BL21 star (DE3) (Invitrogen). The cells were grown in LB medium with ampicillin (100 mug/ml), induced for 4 h by addition of 1 mM isopropyl-beta-d-thiogalacto-pyranoside (IPTG) when the cultures reached an OD of 0.4 at 600 nm. The cells were harvested and resuspended in lysis buffer [25 mM Tris-HCl pH 7.6, 300 mM KCl, 1 mM EDTA, 1 mM DTT, 20% glycerol, 5% NP-40, 0.5 M urea, complete protease inhibitor cocktail (Roche), 1 mM PMSF] sonicated for 5 min and centrifuged at 15 000 r.p.m. for 30 min at 4degreesC. The supernatant was incubated with Ni-NTA Agarose (QIAGEN) overnight at 4degreesC by agitation. Beads were washed four times with washing buffer (25 mM Tris-HCl, pH 7.6, 300 mM KCl, 1 mM DTT, 0.5 M urea, 20% glycerol, 20 mM imidazole). Fusion proteins were eluted from the beads with elution buffer (25 mM Tris-HCl pH 7.6, 50 mM KCl, 1 mM EDTA, 1 mM DTT, 10% glycerol, 0.1% Triton, 0.5 M urea, 200 mM imidazole) for 30 min at 4degreesC.
###end p 21
###begin title 22
RNA binding assays
###end title 22
###begin p 23
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
RNA homopolymer binding assay were performed as described (20). Filter binding assay and gel retardation assay were performed as previously described (18,22).
###end p 23
###begin title 24
Reverse transcriptase-polymerase chain reaction
###end title 24
###begin p 25
###xml 142 149 142 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 151 159 151 159 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3.</label>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 159 235 159 235 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="26">Primers used to quantify relative expression of minigene SXN13 and <italic>FMR1</italic> mRNA</p>
###xml 159 235 159 235 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="26">Primers used to quantify relative expression of minigene SXN13 and <italic>FMR1</italic> mRNA</p></caption>
###xml 235 239 235 239 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene</th>
###xml 239 266 239 266 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Forward and reverse primers</th>
###xml 235 266 235 266 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr>
###xml 235 266 235 266 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead>
###xml 266 288 266 288 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SXN13 alternative exon</td>
###xml 288 314 288 314 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GACCATTCACCACATTGGTG-3&#8242;</td>
###xml 266 314 266 314 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SXN13 alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GACCATTCACCACATTGGTG-3&#8242;</td></tr>
###xml 314 314 314 314 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 314 338 314 338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GAACCTCTGGGTCCAAGG-3&#8242;</td>
###xml 314 338 314 338 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAACCTCTGGGTCCAAGG-3&#8242;</td></tr>
###xml 338 360 338 360 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Primers junction SXN13</td>
###xml 360 383 360 383 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GCCCTGGGCAGGTCGAC-3&#8242;</td>
###xml 338 383 338 383 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Primers junction SXN13</td><td rowspan="1" colspan="1">5&#8242;-GCCCTGGGCAGGTCGAC-3&#8242;</td></tr>
###xml 383 383 383 383 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 383 407 383 407 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GACCACCAGCAGCCTGGA-3&#8242;</td>
###xml 383 407 383 407 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCACCAGCAGCCTGGA-3&#8242;</td></tr>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 407 428 407 428 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>FMR1</italic> alternative exon</td>
###xml 428 454 428 454 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GGAACAAAGGACAGCATCGC-3&#8242;</td>
###xml 407 454 407 454 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>FMR1</italic> alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GGAACAAAGGACAGCATCGC-3&#8242;</td></tr>
###xml 454 454 454 454 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 454 480 454 480 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CCAATCTGTCGCAACTGCTC-3&#8242;</td>
###xml 454 480 454 480 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CCAATCTGTCGCAACTGCTC-3&#8242;</td></tr>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 480 500 480 500 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>FMR1</italic> constituve exon</td>
###xml 500 525 500 525 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CATGCACTTTCGGAGTCTG-3&#8242;</td>
###xml 480 525 480 525 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>FMR1</italic> constituve exon</td><td rowspan="1" colspan="1">5&#8242;-CATGCACTTTCGGAGTCTG-3&#8242;</td></tr>
###xml 525 525 525 525 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 525 550 525 550 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GAAATCTCGAGGCAAGCTG-3&#8242;</td>
###xml 525 550 525 550 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAAATCTCGAGGCAAGCTG-3&#8242;</td></tr>
###xml 550 555 550 555 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GAPDH</td>
###xml 555 581 555 581 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CCACATCGCTCAGACACCAT-3&#8242;</td>
###xml 550 581 550 581 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GAPDH</td><td rowspan="1" colspan="1">5&#8242;-CCACATCGCTCAGACACCAT-3&#8242;</td></tr>
###xml 581 581 581 581 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 581 602 581 602 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GACCAGGCGCCCAAT-3&#8242;</td>
###xml 581 602 581 602 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCAGGCGCCCAAT-3&#8242;</td></tr>
###xml 266 602 266 602 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">SXN13 alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GACCATTCACCACATTGGTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAACCTCTGGGTCCAAGG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">Primers junction SXN13</td><td rowspan="1" colspan="1">5&#8242;-GCCCTGGGCAGGTCGAC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCACCAGCAGCCTGGA-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"><italic>FMR1</italic> alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GGAACAAAGGACAGCATCGC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CCAATCTGTCGCAACTGCTC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"><italic>FMR1</italic> constituve exon</td><td rowspan="1" colspan="1">5&#8242;-CATGCACTTTCGGAGTCTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAAATCTCGAGGCAAGCTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">GAPDH</td><td rowspan="1" colspan="1">5&#8242;-CCACATCGCTCAGACACCAT-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCAGGCGCCCAAT-3&#8242;</td></tr></tbody>
###xml 235 602 235 602 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">SXN13 alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GACCATTCACCACATTGGTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAACCTCTGGGTCCAAGG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">Primers junction SXN13</td><td rowspan="1" colspan="1">5&#8242;-GCCCTGGGCAGGTCGAC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCACCAGCAGCCTGGA-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"><italic>FMR1</italic> alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GGAACAAAGGACAGCATCGC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CCAATCTGTCGCAACTGCTC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"><italic>FMR1</italic> constituve exon</td><td rowspan="1" colspan="1">5&#8242;-CATGCACTTTCGGAGTCTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAAATCTCGAGGCAAGCTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">GAPDH</td><td rowspan="1" colspan="1">5&#8242;-CCACATCGCTCAGACACCAT-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCAGGCGCCCAAT-3&#8242;</td></tr></tbody></table>
###xml 151 602 151 602 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3.</label><caption><p textid="26">Primers used to quantify relative expression of minigene SXN13 and <italic>FMR1</italic> mRNA</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Forward and reverse primers</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">SXN13 alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GACCATTCACCACATTGGTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAACCTCTGGGTCCAAGG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">Primers junction SXN13</td><td rowspan="1" colspan="1">5&#8242;-GCCCTGGGCAGGTCGAC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCACCAGCAGCCTGGA-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"><italic>FMR1</italic> alternative exon</td><td rowspan="1" colspan="1">5&#8242;-GGAACAAAGGACAGCATCGC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-CCAATCTGTCGCAACTGCTC-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"><italic>FMR1</italic> constituve exon</td><td rowspan="1" colspan="1">5&#8242;-CATGCACTTTCGGAGTCTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GAAATCTCGAGGCAAGCTG-3&#8242;</td></tr><tr><td rowspan="1" colspan="1">GAPDH</td><td rowspan="1" colspan="1">5&#8242;-CCACATCGCTCAGACACCAT-3&#8242;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-GACCAGGCGCCCAAT-3&#8242;</td></tr></tbody></table></table-wrap>
Semiquantitative PCR was performed to evaluate the mRNA produced by minigene constructs, using the primers SXN13 alternative exon reported in Table 3. Table 3.Primers used to quantify relative expression of minigene SXN13 and FMR1 mRNAGeneForward and reverse primersSXN13 alternative exon5'-GACCATTCACCACATTGGTG-3'5'-GAACCTCTGGGTCCAAGG-3'Primers junction SXN135'-GCCCTGGGCAGGTCGAC-3'5'-GACCACCAGCAGCCTGGA-3'FMR1 alternative exon5'-GGAACAAAGGACAGCATCGC-3'5'-CCAATCTGTCGCAACTGCTC-3'FMR1 constituve exon5'-CATGCACTTTCGGAGTCTG-3'5'-GAAATCTCGAGGCAAGCTG-3'GAPDH5'-CCACATCGCTCAGACACCAT-3'5'-GACCAGGCGCCCAAT-3'
###end p 25
###begin p 26
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
Primers used to quantify relative expression of minigene SXN13 and FMR1 mRNA
###end p 26
###begin p 27
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 238 245 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 734 757 734 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#9653;&#9653;</sup>
###xml 757 759 737 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT</sup>
###xml 757 759 737 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>CT</sup></italic>
###xml 768 770 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 779 784 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 773 778 <span type="species:ncbi:9606">Human</span>
We evaluated the inclusion of exon 2 of the SXN13 minigene and of exon 14 of FMR1 gene by quantitative RT-PCR as we have recently described (23). The sequences of primers and PCR conditions used in this set of experiments are reported in Table 3. RNA was purified from HeLa cells, normal and FRAXE fibroblasts using the RNeasy kit (Qiagen) and retro-transcribed by the Thermoscript RT-PCR System (Invitrogen). Real-time PCR was performed using a 7000 Sequence Detection System (Applied Biosystem) using the cDNA, qPCR Core kit for SYBR Green (Eurogentec) according to the manufacturer's instructions and 200 nM of each primer. All experiments were performed in triplicate. The relative expression of transcripts was quantified using 2-triangle uptriangle upCT method (24). Human GAPDH was used as endogenous control.
###end p 27
###begin p 28
PCR amplification for real-time PCR was performed with 40 cycles of denaturation at 95degreesC for 15 s and annealing/extension at 60degreesC for 60 s. Detection of PCR product was monitored by measuring the increase in fluorescence caused by the binding of SYBR Green to double-stranded DNA.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30
Localization and functional domains of FMR2
###end title 30
###begin p 31
###xml 300 308 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 422 430 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 636 644 636 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 832 840 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 956 965 956 965 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1172 1176 1172 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 1178 1179 1178 1179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1201 1202 1201 1202 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1240 1241 1240 1241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 965 1533 965 1531 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="32">Endogenous and overexpressed FMR2 localizes to nuclear speckles. Co-localization of FMR2 with SC35 in nuclear speckles as detected by polyclonal anti-FMR2 antibody in Hela cells transfected with full-length <italic>FMR2</italic> (<bold>A</bold>) and in NG108 cells (<bold>B</bold>) and in primary hippocampal neurons (<bold>C</bold>) expressing endogenous FMR2. FMR2 was detected with polyclonal anti-FMR2 antibody and SC35 was detected by monoclonal anti-SC35 antibody. (A) 63&#215; magnification, scale bar 5&#8194;&#956;m. (B and C) 40&#215; magnification, scale bar 10&#8194;&#956;m. Twenty-five 40&#215; fields were analyzed, showing a comparable result.</p>
###xml 965 1533 965 1531 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="32">Endogenous and overexpressed FMR2 localizes to nuclear speckles. Co-localization of FMR2 with SC35 in nuclear speckles as detected by polyclonal anti-FMR2 antibody in Hela cells transfected with full-length <italic>FMR2</italic> (<bold>A</bold>) and in NG108 cells (<bold>B</bold>) and in primary hippocampal neurons (<bold>C</bold>) expressing endogenous FMR2. FMR2 was detected with polyclonal anti-FMR2 antibody and SC35 was detected by monoclonal anti-SC35 antibody. (A) 63&#215; magnification, scale bar 5&#8194;&#956;m. (B and C) 40&#215; magnification, scale bar 10&#8194;&#956;m. Twenty-five 40&#215; fields were analyzed, showing a comparable result.</p></caption>
###xml 1533 1533 1531 1531 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1058f1"/>
###xml 956 1533 956 1531 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="32">Endogenous and overexpressed FMR2 localizes to nuclear speckles. Co-localization of FMR2 with SC35 in nuclear speckles as detected by polyclonal anti-FMR2 antibody in Hela cells transfected with full-length <italic>FMR2</italic> (<bold>A</bold>) and in NG108 cells (<bold>B</bold>) and in primary hippocampal neurons (<bold>C</bold>) expressing endogenous FMR2. FMR2 was detected with polyclonal anti-FMR2 antibody and SC35 was detected by monoclonal anti-SC35 antibody. (A) 63&#215; magnification, scale bar 5&#8194;&#956;m. (B and C) 40&#215; magnification, scale bar 10&#8194;&#956;m. Twenty-five 40&#215; fields were analyzed, showing a comparable result.</p></caption><graphic xlink:href="gkn1058f1"/></fig>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
To get insight into FMR2 function, we performed a detailed study of its intracellular localization by generating a polyclonal anti-FMR2 antibody using a synthetic peptide corresponding to amino acids 116-133 of mouse FMR2 (see ). We then transfected HeLa cells (which do not express endogenous FMR2, Figure 1 and ) with a construct encoding full-length FMR2 and we revealed its nuclear localization in a dot-like pattern (Figure 1A). This same result was obtained with a Flag-tagged-FMR2 (not shown). Our anti-FMR2 antibody recognizes endogenous FMR2 protein in neuroblastoma NG108 cells (Figure 1B) and in primary hippocampal neurons (Figure 1C). Intriguingly, both endogenous and transfected FMR2 are present in the nucleus in large dots colocalized with nuclear speckle domains, as revealed by the anti-SC35 monoclonal antibody (Figure 1, ). These nuclear domains represent sites where splicing factors are concentrated, assembled and modified (25) (). Figure 1.Endogenous and overexpressed FMR2 localizes to nuclear speckles. Co-localization of FMR2 with SC35 in nuclear speckles as detected by polyclonal anti-FMR2 antibody in Hela cells transfected with full-length FMR2 (A) and in NG108 cells (B) and in primary hippocampal neurons (C) expressing endogenous FMR2. FMR2 was detected with polyclonal anti-FMR2 antibody and SC35 was detected by monoclonal anti-SC35 antibody. (A) 63x magnification, scale bar 5 mum. (B and C) 40x magnification, scale bar 10 mum. Twenty-five 40x fields were analyzed, showing a comparable result.
###end p 31
###begin p 32
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 213 214 213 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 275 276 275 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Endogenous and overexpressed FMR2 localizes to nuclear speckles. Co-localization of FMR2 with SC35 in nuclear speckles as detected by polyclonal anti-FMR2 antibody in Hela cells transfected with full-length FMR2 (A) and in NG108 cells (B) and in primary hippocampal neurons (C) expressing endogenous FMR2. FMR2 was detected with polyclonal anti-FMR2 antibody and SC35 was detected by monoclonal anti-SC35 antibody. (A) 63x magnification, scale bar 5 mum. (B and C) 40x magnification, scale bar 10 mum. Twenty-five 40x fields were analyzed, showing a comparable result.
###end p 32
###begin p 33
###xml 393 401 393 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 528 536 528 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 800 809 800 809 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 864 865 864 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 938 939 938 939 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 996 997 996 997 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 809 1276 809 1275 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">FMR2 determinants for its intracellular localization. (<bold>A</bold>) Co-localization of C-ter with SC35 in nuclear speckles in Hela cells. (<bold>B</bold>) Localization of N-ter in the cytoplasm of HeLa cells. (<bold>C</bold>) Nucleolar localization of C1 in HeLa. All FMR2 domains have been detected using the polyclonal anti-Flag antibody, and SC35 was detected by the anti SC35 monoclonal antibody. The 40&#215; magnification, scale bar 10&#8194;&#956;m. Twenty 40&#215; fields were analyzed, showing a comparable result.</p>
###xml 809 1276 809 1275 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">FMR2 determinants for its intracellular localization. (<bold>A</bold>) Co-localization of C-ter with SC35 in nuclear speckles in Hela cells. (<bold>B</bold>) Localization of N-ter in the cytoplasm of HeLa cells. (<bold>C</bold>) Nucleolar localization of C1 in HeLa. All FMR2 domains have been detected using the polyclonal anti-Flag antibody, and SC35 was detected by the anti SC35 monoclonal antibody. The 40&#215; magnification, scale bar 10&#8194;&#956;m. Twenty 40&#215; fields were analyzed, showing a comparable result.</p></caption>
###xml 1276 1276 1275 1275 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1058f2"/>
###xml 800 1276 800 1275 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="34">FMR2 determinants for its intracellular localization. (<bold>A</bold>) Co-localization of C-ter with SC35 in nuclear speckles in Hela cells. (<bold>B</bold>) Localization of N-ter in the cytoplasm of HeLa cells. (<bold>C</bold>) Nucleolar localization of C1 in HeLa. All FMR2 domains have been detected using the polyclonal anti-Flag antibody, and SC35 was detected by the anti SC35 monoclonal antibody. The 40&#215; magnification, scale bar 10&#8194;&#956;m. Twenty 40&#215; fields were analyzed, showing a comparable result.</p></caption><graphic xlink:href="gkn1058f2"/></fig>
To define the functional properties of FMR2 domains, we divided FMR2 into three regions and subcloned them fused to Flag-tag: N-ter (residues 1-640), C-ter (residues 633-1272), C1 (residues 633-966). We used these constructs to transfect HeLa cells and their protein products were revealed by immunofluorescence using the anti-Flag antibody. The N-ter construct is localized in the cytoplasm (Figure 2), while C-ter exhibits the same nuclear distribution as the full-length protein, co-localizing with SC35 and C1 is nucleolar (Figure 2) (in  the co-localization of C1 with fibrillarin as a nucleolar marker is shown). We conclude that the C-ter domain is determinant for the speckle localization of FMR2. Interestingly, this domain also contains a nucleolar localization signal in its C1 subdomain. Figure 2.FMR2 determinants for its intracellular localization. (A) Co-localization of C-ter with SC35 in nuclear speckles in Hela cells. (B) Localization of N-ter in the cytoplasm of HeLa cells. (C) Nucleolar localization of C1 in HeLa. All FMR2 domains have been detected using the polyclonal anti-Flag antibody, and SC35 was detected by the anti SC35 monoclonal antibody. The 40x magnification, scale bar 10 mum. Twenty 40x fields were analyzed, showing a comparable result.
###end p 33
###begin p 34
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 130 129 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 187 188 187 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
FMR2 determinants for its intracellular localization. (A) Co-localization of C-ter with SC35 in nuclear speckles in Hela cells. (B) Localization of N-ter in the cytoplasm of HeLa cells. (C) Nucleolar localization of C1 in HeLa. All FMR2 domains have been detected using the polyclonal anti-Flag antibody, and SC35 was detected by the anti SC35 monoclonal antibody. The 40x magnification, scale bar 10 mum. Twenty 40x fields were analyzed, showing a comparable result.
###end p 34
###begin title 35
Dynamic behaviour of FMR2
###end title 35
###begin p 36
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 492 500 492 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 822 830 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 964 972 964 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1091 1100 1091 1100 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1187 1188 1187 1188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1663 1664 1662 1663 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1100 2146 1100 2143 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">Blocking of transcription and splicing affects nuclear speckles localization of FMR2. (<bold>A</bold>) Blocking of transcription in NG108 neuroblastoma cells by ActD. The treatment affects the morphology and number of nuclear speckles, as revealed by detection of SC35 with anti-SC35 antibody. FMR2 is co-localized with SC35 in control cells and after treatment, as detected by the anti-FMR2 antibody. In ActD-treated cells, FMR2 is also localized in the cytoplasm. The 40&#215; magnification, scale bar 10 &#956;m. Twenty-five 40&#215; fields were analysed, showing a comparable results. (<bold>B</bold>) Blocking of splicing in SK-N-SH neuroblastoma cells. In U6 antisense-microinjected cells, SC35 is accumulated in enlarged nuclear speckles, as detected by monoclonal anti-SC35 antibody. In these cells, FMR2 is co-localized with SC35 and is also concentrated in the nucleoli, as detected by polyclonal anti-FMR2 antibody. Upper panels, 20&#215; magnification, scale bar 10 &#956;m; lower panels, 63&#215; magnification, scale bar 5 &#956;m. Ten 20&#215; fields were analysed, showing a comparable result.</p>
###xml 1100 2146 1100 2143 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">Blocking of transcription and splicing affects nuclear speckles localization of FMR2. (<bold>A</bold>) Blocking of transcription in NG108 neuroblastoma cells by ActD. The treatment affects the morphology and number of nuclear speckles, as revealed by detection of SC35 with anti-SC35 antibody. FMR2 is co-localized with SC35 in control cells and after treatment, as detected by the anti-FMR2 antibody. In ActD-treated cells, FMR2 is also localized in the cytoplasm. The 40&#215; magnification, scale bar 10 &#956;m. Twenty-five 40&#215; fields were analysed, showing a comparable results. (<bold>B</bold>) Blocking of splicing in SK-N-SH neuroblastoma cells. In U6 antisense-microinjected cells, SC35 is accumulated in enlarged nuclear speckles, as detected by monoclonal anti-SC35 antibody. In these cells, FMR2 is co-localized with SC35 and is also concentrated in the nucleoli, as detected by polyclonal anti-FMR2 antibody. Upper panels, 20&#215; magnification, scale bar 10 &#956;m; lower panels, 63&#215; magnification, scale bar 5 &#956;m. Ten 20&#215; fields were analysed, showing a comparable result.</p></caption>
###xml 2146 2146 2143 2143 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1058f3"/>
###xml 1091 2146 1091 2143 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="37">Blocking of transcription and splicing affects nuclear speckles localization of FMR2. (<bold>A</bold>) Blocking of transcription in NG108 neuroblastoma cells by ActD. The treatment affects the morphology and number of nuclear speckles, as revealed by detection of SC35 with anti-SC35 antibody. FMR2 is co-localized with SC35 in control cells and after treatment, as detected by the anti-FMR2 antibody. In ActD-treated cells, FMR2 is also localized in the cytoplasm. The 40&#215; magnification, scale bar 10 &#956;m. Twenty-five 40&#215; fields were analysed, showing a comparable results. (<bold>B</bold>) Blocking of splicing in SK-N-SH neuroblastoma cells. In U6 antisense-microinjected cells, SC35 is accumulated in enlarged nuclear speckles, as detected by monoclonal anti-SC35 antibody. In these cells, FMR2 is co-localized with SC35 and is also concentrated in the nucleoli, as detected by polyclonal anti-FMR2 antibody. Upper panels, 20&#215; magnification, scale bar 10 &#956;m; lower panels, 63&#215; magnification, scale bar 5 &#956;m. Ten 20&#215; fields were analysed, showing a comparable result.</p></caption><graphic xlink:href="gkn1058f3"/></fig>
Nuclear speckles are dynamic structures whose size and shape vary according to the level of RNA polymerase II-dependent transcription and splicing activity (25). For this reason, we investigated whether inhibition of splicing or transcription have an impact on FMR2 intracellular localization (21,26). First, we studied the subcellular distribution of SC35 and FMR2 in NG108 cells after blocking transcription by ActD. As expected, SC35 appears redistributed into enlarged, rounded speckles (Figure 3A), similar to other splicing factors (26). Interestingly, we observed that a portion of FMR2 protein is co-localized with SC35. We also blocked splicing in living cells by injecting the antisense U6 oligonucleotide in the SK-N-SH neuroblastoma cell line. This led to the accumulation of SC35 in enlarged speckle domains (Figure 3B). In these conditions FMR2 is partially co-localized with SC35 in these speckles-like structures and also concentrated in nucleoli (Figure 3B). Taken together, these data strongly suggest that FMR2 is involved in splicing and may have RNA-binding properties. Figure 3.Blocking of transcription and splicing affects nuclear speckles localization of FMR2. (A) Blocking of transcription in NG108 neuroblastoma cells by ActD. The treatment affects the morphology and number of nuclear speckles, as revealed by detection of SC35 with anti-SC35 antibody. FMR2 is co-localized with SC35 in control cells and after treatment, as detected by the anti-FMR2 antibody. In ActD-treated cells, FMR2 is also localized in the cytoplasm. The 40x magnification, scale bar 10 mum. Twenty-five 40x fields were analysed, showing a comparable results. (B) Blocking of splicing in SK-N-SH neuroblastoma cells. In U6 antisense-microinjected cells, SC35 is accumulated in enlarged nuclear speckles, as detected by monoclonal anti-SC35 antibody. In these cells, FMR2 is co-localized with SC35 and is also concentrated in the nucleoli, as detected by polyclonal anti-FMR2 antibody. Upper panels, 20x magnification, scale bar 10 mum; lower panels, 63x magnification, scale bar 5 mum. Ten 20x fields were analysed, showing a comparable result.
###end p 36
###begin p 37
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 563 564 562 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Blocking of transcription and splicing affects nuclear speckles localization of FMR2. (A) Blocking of transcription in NG108 neuroblastoma cells by ActD. The treatment affects the morphology and number of nuclear speckles, as revealed by detection of SC35 with anti-SC35 antibody. FMR2 is co-localized with SC35 in control cells and after treatment, as detected by the anti-FMR2 antibody. In ActD-treated cells, FMR2 is also localized in the cytoplasm. The 40x magnification, scale bar 10 mum. Twenty-five 40x fields were analysed, showing a comparable results. (B) Blocking of splicing in SK-N-SH neuroblastoma cells. In U6 antisense-microinjected cells, SC35 is accumulated in enlarged nuclear speckles, as detected by monoclonal anti-SC35 antibody. In these cells, FMR2 is co-localized with SC35 and is also concentrated in the nucleoli, as detected by polyclonal anti-FMR2 antibody. Upper panels, 20x magnification, scale bar 10 mum; lower panels, 63x magnification, scale bar 5 mum. Ten 20x fields were analysed, showing a comparable result.
###end p 37
###begin title 38
FMR2 is an RNA-binding protein
###end title 38
###begin p 39
###xml 178 186 178 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 448 456 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 488 496 488 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1167 1171 1167 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1282 1286 1282 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1322 1324 1322 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1456 1464 1456 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1552 1561 1552 1561 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1593 1594 1593 1594 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1596 1604 1596 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1617 1619 1617 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1842 1843 1841 1842 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</bold>
###xml 1852 1853 1851 1852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
###xml 1885 1886 1884 1885 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1988 1989 1987 1988 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
###xml 1561 2155 1561 2154 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">FMR2 is an RNA-binding protein.(<bold>A</bold>) <italic>In vitro</italic> translated [<sup>35</sup>S] methionine labelled full-length FMR2, full-length FMRP, N-ter and C-ter proteins were incubated with each RNA homopolymer linked to agarose in the presence of 0.25 M KCl. The same volume (10 &#956;l) of each eluate was analy<bold>s</bold>ed by SDS<bold>&#8211;</bold>PAGE followed by fluorography. (<bold>B</bold>) Labelled N19 probe was incubated in the presence of increasing amounts of recombinant N-ter (lanes 2<bold>&#8211;</bold>4: 0.2, 0.4 and 0.6 pmol, respectively) and C-ter (lanes 5&#8211;7: 0.2, 0.4 and 0.6 pmol, respectively) proteins. As a control, the labelled N19 probe was shown in lane 1.</p>
###xml 1561 2155 1561 2154 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">FMR2 is an RNA-binding protein.(<bold>A</bold>) <italic>In vitro</italic> translated [<sup>35</sup>S] methionine labelled full-length FMR2, full-length FMRP, N-ter and C-ter proteins were incubated with each RNA homopolymer linked to agarose in the presence of 0.25 M KCl. The same volume (10 &#956;l) of each eluate was analy<bold>s</bold>ed by SDS<bold>&#8211;</bold>PAGE followed by fluorography. (<bold>B</bold>) Labelled N19 probe was incubated in the presence of increasing amounts of recombinant N-ter (lanes 2<bold>&#8211;</bold>4: 0.2, 0.4 and 0.6 pmol, respectively) and C-ter (lanes 5&#8211;7: 0.2, 0.4 and 0.6 pmol, respectively) proteins. As a control, the labelled N19 probe was shown in lane 1.</p></caption>
###xml 2155 2155 2154 2154 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1058f4"/>
###xml 1552 2155 1552 2154 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="40">FMR2 is an RNA-binding protein.(<bold>A</bold>) <italic>In vitro</italic> translated [<sup>35</sup>S] methionine labelled full-length FMR2, full-length FMRP, N-ter and C-ter proteins were incubated with each RNA homopolymer linked to agarose in the presence of 0.25 M KCl. The same volume (10 &#956;l) of each eluate was analy<bold>s</bold>ed by SDS<bold>&#8211;</bold>PAGE followed by fluorography. (<bold>B</bold>) Labelled N19 probe was incubated in the presence of increasing amounts of recombinant N-ter (lanes 2<bold>&#8211;</bold>4: 0.2, 0.4 and 0.6 pmol, respectively) and C-ter (lanes 5&#8211;7: 0.2, 0.4 and 0.6 pmol, respectively) proteins. As a control, the labelled N19 probe was shown in lane 1.</p></caption><graphic xlink:href="gkn1058f4"/></fig>
To validate our hypothesis, we tested the ability of FMR2 to bind synthetic RNA homopolymers. Indeed, FMR2 selectively binds to poly (G), but not poly (A), poly (C) or poly (U) (Figure 4A) while the control FMRP (Fragile X Mental Retardation Protein), as expected, is able to bind to poly (G) and poly (U) (20). The binding activity to poly (G) was retained by the FMR2 C-ter domain, the same region directing its localization in nuclear speckles (Figure 2), but not by the N-ter domain (Figure 2). Even if no homology with other RNA-binding domains is present in FMR2, two putative RNA-binding motifs were identified within this region (the first between residues 787 and 815 and the second between residues 890 and 917) using the RNABindR program (27). Since FMR2 has affinity for poly (G) RNA, we questioned whether it can bind any RNA containing a stretch of G nucleotides or if it is able to recognize and bind a specific G-rich RNA structure. For this reason, we tested the ability of N-ter and C-ter recombinant FMR2 proteins to bind a RNA probe containing a G-quartet forming structure, the N-19 RNA in a gel retardation assay. Previously, we have shown that FMR1 mRNA contains a G-quartet forming structure, the N19 sequence, localized between nucleotides 1470 and 1896 of FMR1, which is bound by FMRP itself (18,28). Indeed, as for the poly G-sequence increasing amounts of C-ter bind the N19 probe while of N-ter does not interact with the RNA (Figure 4B), suggesting a specificity of FMR2 for G-quartet structure via its C-terminal domain. Figure 4.FMR2 is an RNA-binding protein.(A) In vitro translated [35S] methionine labelled full-length FMR2, full-length FMRP, N-ter and C-ter proteins were incubated with each RNA homopolymer linked to agarose in the presence of 0.25 M KCl. The same volume (10 mul) of each eluate was analysed by SDS-PAGE followed by fluorography. (B) Labelled N19 probe was incubated in the presence of increasing amounts of recombinant N-ter (lanes 2-4: 0.2, 0.4 and 0.6 pmol, respectively) and C-ter (lanes 5-7: 0.2, 0.4 and 0.6 pmol, respectively) proteins. As a control, the labelled N19 probe was shown in lane 1.
###end p 39
###begin p 40
###xml 32 33 32 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 281 282 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</bold>
###xml 291 292 290 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
###xml 324 325 323 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 427 428 426 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
FMR2 is an RNA-binding protein.(A) In vitro translated [35S] methionine labelled full-length FMR2, full-length FMRP, N-ter and C-ter proteins were incubated with each RNA homopolymer linked to agarose in the presence of 0.25 M KCl. The same volume (10 mul) of each eluate was analysed by SDS-PAGE followed by fluorography. (B) Labelled N19 probe was incubated in the presence of increasing amounts of recombinant N-ter (lanes 2-4: 0.2, 0.4 and 0.6 pmol, respectively) and C-ter (lanes 5-7: 0.2, 0.4 and 0.6 pmol, respectively) proteins. As a control, the labelled N19 probe was shown in lane 1.
###end p 40
###begin title 41
FMR2 has high affinity for the G-quartet RNA structure
###end title 41
###begin p 42
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 820 828 820 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 847 855 847 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1002 1010 1002 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1041 1042 1041 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1098 1106 1098 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1283 1285 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1286 1288 1286 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1577 1585 1577 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1759 1761 1759 1761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1762 1764 1762 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1765 1767 1765 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1847 1852 1847 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2Ac</italic>
###xml 1893 1895 1893 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1974 1982 1974 1982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 2142 2150 2142 2150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 2174 2178 2174 2178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 2269 2277 2269 2277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 2389 2397 2379 2387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 2412 2414 2402 2404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 2481 2489 2471 2479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 2576 2585 2566 2575 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 2648 2649 2638 2639 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2865 2866 2845 2846 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2986 2987 2966 2967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3026 3027 3006 3007 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3063 3064 3043 3044 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3100 3101 3080 3081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3110 3111 3090 3091 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3138 3139 3118 3119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 3270 3275 3250 3255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2Ac</italic>
###xml 3356 3357 3336 3337 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 3485 3486 3465 3466 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 2585 3713 2575 3683 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">FMR2 binds with high specificity the G-quartet RNA structure. (<bold>A</bold>) Sequence of the FBS purine-rich region encompassing the G-quartet forming structure inside the N19 RNA. The 35 nucleotides indicated in bold and underlined were deleted to generate the &#934;B&#931; &#916;35 sequence. (<bold>B</bold>) Filter-binding assay using increasing amounts of full-length FMR2, FMRP, N-ter and C-ter proteins in the presence of K<sup>+</sup> using the N19 RNA as labelled probe. (<bold>C</bold>) The same experience described in (<bold>B</bold>) was repeated in the presence of Na<sup>+</sup> and in (<bold>D</bold>) in the presence of Li+. (<bold>E</bold>) Competition experiments in a nitrocellulose binding assay using the N19 unlabelled RNA as competitor and the unlabelled 3&#8242;UTR of <italic>PP2Ac</italic> RNA (N8) not containing any G-quartet forming structure as a negative control. (<bold>F</bold>) Filter-binding assay using an increasing amount of full-length FMR2, FMRP and C-ter proteins. The labelled probe is FBS RNA. (<bold>G</bold>) Filter-binding assay using an increasing amount of full-length FMR2 and C-ter proteins. The labelled probe is the &#934;B&#931; &#916;35 RNA. Each point shows the mean of the results obtained in three independent experiments (see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn1058/DC1">Supplementary Table 1</ext-link> for details of each binding assay).</p>
###xml 2585 3749 2575 3719 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">FMR2 binds with high specificity the G-quartet RNA structure. (<bold>A</bold>) Sequence of the FBS purine-rich region encompassing the G-quartet forming structure inside the N19 RNA. The 35 nucleotides indicated in bold and underlined were deleted to generate the &#934;B&#931; &#916;35 sequence. (<bold>B</bold>) Filter-binding assay using increasing amounts of full-length FMR2, FMRP, N-ter and C-ter proteins in the presence of K<sup>+</sup> using the N19 RNA as labelled probe. (<bold>C</bold>) The same experience described in (<bold>B</bold>) was repeated in the presence of Na<sup>+</sup> and in (<bold>D</bold>) in the presence of Li+. (<bold>E</bold>) Competition experiments in a nitrocellulose binding assay using the N19 unlabelled RNA as competitor and the unlabelled 3&#8242;UTR of <italic>PP2Ac</italic> RNA (N8) not containing any G-quartet forming structure as a negative control. (<bold>F</bold>) Filter-binding assay using an increasing amount of full-length FMR2, FMRP and C-ter proteins. The labelled probe is FBS RNA. (<bold>G</bold>) Filter-binding assay using an increasing amount of full-length FMR2 and C-ter proteins. The labelled probe is the &#934;B&#931; &#916;35 RNA. Each point shows the mean of the results obtained in three independent experiments (see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn1058/DC1">Supplementary Table 1</ext-link> for details of each binding assay).</p></caption>
###xml 3749 3749 3719 3719 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1058f5"/>
###xml 2576 3749 2566 3719 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="43">FMR2 binds with high specificity the G-quartet RNA structure. (<bold>A</bold>) Sequence of the FBS purine-rich region encompassing the G-quartet forming structure inside the N19 RNA. The 35 nucleotides indicated in bold and underlined were deleted to generate the &#934;B&#931; &#916;35 sequence. (<bold>B</bold>) Filter-binding assay using increasing amounts of full-length FMR2, FMRP, N-ter and C-ter proteins in the presence of K<sup>+</sup> using the N19 RNA as labelled probe. (<bold>C</bold>) The same experience described in (<bold>B</bold>) was repeated in the presence of Na<sup>+</sup> and in (<bold>D</bold>) in the presence of Li+. (<bold>E</bold>) Competition experiments in a nitrocellulose binding assay using the N19 unlabelled RNA as competitor and the unlabelled 3&#8242;UTR of <italic>PP2Ac</italic> RNA (N8) not containing any G-quartet forming structure as a negative control. (<bold>F</bold>) Filter-binding assay using an increasing amount of full-length FMR2, FMRP and C-ter proteins. The labelled probe is FBS RNA. (<bold>G</bold>) Filter-binding assay using an increasing amount of full-length FMR2 and C-ter proteins. The labelled probe is the &#934;B&#931; &#916;35 RNA. Each point shows the mean of the results obtained in three independent experiments (see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn1058/DC1">Supplementary Table 1</ext-link> for details of each binding assay).</p></caption><graphic xlink:href="gkn1058f5"/></fig>
G-quartets or quadruplexes are four stranded nucleic acid structures formed by stacking of planar layers of guanine tetrad units. In the tetrads, four guanines interact two by two in a cyclic Hoogsteen hydrogen bonding arrangement. G-quartet RNA folds in a 3D structure preferentially in the presence of K+ ions in comparison with Li+ and Na+ ions (18,29), as it was also shown for G-quartet RNA structure localized in FMR1 mRNA (18,22). To test our hypothesis, we generated recombinant N-ter, C-ter and full-length His-tagged FMR2 proteins and we performed a filter-binding assay with the N19 probe, using FMRP as a positive control. Surprisingly, in the presence of K+, full-length FMR2 and C-ter proteins were able to bind N19 as tightly as FMRP, whereas the N-terminal domain, in agreement with the results shown in Figure 4A and 4B, was not (Figure 5B). Additionally, in the presence of Na+, that partially destabilizes the G-quartet formation, FMR2 and C-ter bound to N19 to a much lower extent (Figure 5C), while in the presence of Li+ the binding of FMR2 proteins to N19 RNA was abolished (Figure 5D). To measure binding affinity we used competition assays that are more sensitive and allow for alleviation of the contribution of the non-specific binding properties of FMR2 (18,22). Therefore a constant concentration of labeled N19 RNA was incubated with a fixed amount of His-FMR2 and C-ter in the presence of increasing concentrations of unlabeled N19 RNA as a competitor. Binding of FMR2 and C-ter to the labeled N19 RNA was efficiently competed by the cold probe (Figure 5E). As little as 1 nM of competitor RNA is able to displace 50% of FMR2 from the G-quartet labeled probe, an affinity comparable to that of FMRP for G-quartet RNA structure (17,18,22). When we used the unlabelled N8 competitor RNA (corresponding to the 3'UTR of PP2Ac mRNA and not containing G-quartet RNA) (17) as a negative control, no displacement of the binding was observed for FMR2 (Figure 5E). Then we tested the ability of FMR2 and C-ter to bind the FBS (FMRP binding site) RNA, encompassing only the G-quartet forming structure inside the N19 RNA (Figure 5A) (nt 1557-1658 of the FMR1 mRNA coding region), FMRP, FMR2 and C-ter proteins were able to bind specifically to FBS (Figure 5F). Conversely, when we deleted the G-quartet structure generating the PhiBSigma Delta35 sequence [described in Figure 5A and in ref. (18)] full-length FMR2 and its C-terminal domain were unable to bind (Figure 5G). We can conclude that FMR2 binds G-quartet RNA specifically and with high affinity. Figure 5.FMR2 binds with high specificity the G-quartet RNA structure. (A) Sequence of the FBS purine-rich region encompassing the G-quartet forming structure inside the N19 RNA. The 35 nucleotides indicated in bold and underlined were deleted to generate the PhiBSigma Delta35 sequence. (B) Filter-binding assay using increasing amounts of full-length FMR2, FMRP, N-ter and C-ter proteins in the presence of K+ using the N19 RNA as labelled probe. (C) The same experience described in (B) was repeated in the presence of Na+ and in (D) in the presence of Li+. (E) Competition experiments in a nitrocellulose binding assay using the N19 unlabelled RNA as competitor and the unlabelled 3'UTR of PP2Ac RNA (N8) not containing any G-quartet forming structure as a negative control. (F) Filter-binding assay using an increasing amount of full-length FMR2, FMRP and C-ter proteins. The labelled probe is FBS RNA. (G) Filter-binding assay using an increasing amount of full-length FMR2 and C-ter proteins. The labelled probe is the PhiBSigma Delta35 RNA. Each point shows the mean of the results obtained in three independent experiments (see  for details of each binding assay).
###end p 42
###begin p 43
###xml 63 64 63 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 280 281 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 401 402 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 442 431 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 478 479 468 469 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 515 516 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 525 526 515 516 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 553 554 543 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 685 690 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP2Ac</italic>
###xml 771 772 761 762 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 900 901 890 891 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
FMR2 binds with high specificity the G-quartet RNA structure. (A) Sequence of the FBS purine-rich region encompassing the G-quartet forming structure inside the N19 RNA. The 35 nucleotides indicated in bold and underlined were deleted to generate the PhiBSigma Delta35 sequence. (B) Filter-binding assay using increasing amounts of full-length FMR2, FMRP, N-ter and C-ter proteins in the presence of K+ using the N19 RNA as labelled probe. (C) The same experience described in (B) was repeated in the presence of Na+ and in (D) in the presence of Li+. (E) Competition experiments in a nitrocellulose binding assay using the N19 unlabelled RNA as competitor and the unlabelled 3'UTR of PP2Ac RNA (N8) not containing any G-quartet forming structure as a negative control. (F) Filter-binding assay using an increasing amount of full-length FMR2, FMRP and C-ter proteins. The labelled probe is FBS RNA. (G) Filter-binding assay using an increasing amount of full-length FMR2 and C-ter proteins. The labelled probe is the PhiBSigma Delta35 RNA. Each point shows the mean of the results obtained in three independent experiments (see  for details of each binding assay).
###end p 43
###begin title 44
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
FMR2/G-quartet RNA interaction in vivo
###end title 44
###begin p 45
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 683 691 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1307 1314 1307 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 1329 1337 1329 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 2522 2529 2522 2529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2633 2637 2633 2637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 2769 2771 2769 2771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 2828 2830 2828 2830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 2919 2923 2919 2923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3016 3020 3016 3020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 3077 3078 3077 3078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 3217 3221 3217 3221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3299 3307 3299 3307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 3391 3395 3391 3395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3450 3454 3450 3454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3506 3510 3506 3510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 3512 3520 3512 3520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 3579 3583 3579 3583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3648 3656 3648 3656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 3729 3733 3729 3733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3758 3767 3758 3767 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 3869 3873 3869 3873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3887 3888 3887 3888 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 4125 4126 4125 4126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 4407 4412 4407 4412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 4479 4480 4479 4480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 4509 4513 4509 4513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 4574 4575 4574 4575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 4600 4604 4600 4604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 4751 4755 4751 4755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 4814 4815 4814 4815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 4867 4871 4867 4871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 5004 5008 5004 5008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 5087 5091 5087 5091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3767 5127 3767 5127 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">Effect of FMR2 on splicing of an alternative exon in minigene-transfected cells and in the endogenous <italic>FMR1</italic> transcript. (<bold>A</bold>) Schematic representation of SXN13 minigene and of SXN13/FBS minigene. This last one includes G-quartet in exon 2. Visualization of splicing products of the minigene by semiquantitative RT&#8211;PCR. Black arrows indicate primers positions. (<bold>B</bold>) Relative expression of the inclusion of minigene exon 2 using real-time quantitative PCR in the presence or in the absence of FMR2, C-ter and N-ter proteins. Results were obtained by analysis of three independent transfection experiments. Red arrows indicate primers postitions, <italic>GAPDH</italic> was used as a standard. Error bars represent standard deviation. (<bold>C</bold>) Schematic structure of the <italic>FMR1</italic> full-length mRNA, showing alternative splicing of exon 14. (<bold>D</bold>) Relative expression of <italic>FMR1</italic> constitutive exons 7&#8211;8 using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of <italic>FMR2</italic> gene. No difference is observed between the two samples. (<bold>E</bold>) Relative expression of exon 14 sequence-including <italic>FMR1</italic> isoforms using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of <italic>FMR2</italic> gene. An increased expression level of 50% is observed for exon 14-containing <italic>FMR1</italic> isoforms mRNA in FRAXE fibroblasts.</p>
###xml 3767 5127 3767 5127 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">Effect of FMR2 on splicing of an alternative exon in minigene-transfected cells and in the endogenous <italic>FMR1</italic> transcript. (<bold>A</bold>) Schematic representation of SXN13 minigene and of SXN13/FBS minigene. This last one includes G-quartet in exon 2. Visualization of splicing products of the minigene by semiquantitative RT&#8211;PCR. Black arrows indicate primers positions. (<bold>B</bold>) Relative expression of the inclusion of minigene exon 2 using real-time quantitative PCR in the presence or in the absence of FMR2, C-ter and N-ter proteins. Results were obtained by analysis of three independent transfection experiments. Red arrows indicate primers postitions, <italic>GAPDH</italic> was used as a standard. Error bars represent standard deviation. (<bold>C</bold>) Schematic structure of the <italic>FMR1</italic> full-length mRNA, showing alternative splicing of exon 14. (<bold>D</bold>) Relative expression of <italic>FMR1</italic> constitutive exons 7&#8211;8 using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of <italic>FMR2</italic> gene. No difference is observed between the two samples. (<bold>E</bold>) Relative expression of exon 14 sequence-including <italic>FMR1</italic> isoforms using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of <italic>FMR2</italic> gene. An increased expression level of 50% is observed for exon 14-containing <italic>FMR1</italic> isoforms mRNA in FRAXE fibroblasts.</p></caption>
###xml 5127 5127 5127 5127 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1058f6"/>
###xml 3758 5127 3758 5127 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="46">Effect of FMR2 on splicing of an alternative exon in minigene-transfected cells and in the endogenous <italic>FMR1</italic> transcript. (<bold>A</bold>) Schematic representation of SXN13 minigene and of SXN13/FBS minigene. This last one includes G-quartet in exon 2. Visualization of splicing products of the minigene by semiquantitative RT&#8211;PCR. Black arrows indicate primers positions. (<bold>B</bold>) Relative expression of the inclusion of minigene exon 2 using real-time quantitative PCR in the presence or in the absence of FMR2, C-ter and N-ter proteins. Results were obtained by analysis of three independent transfection experiments. Red arrows indicate primers postitions, <italic>GAPDH</italic> was used as a standard. Error bars represent standard deviation. (<bold>C</bold>) Schematic structure of the <italic>FMR1</italic> full-length mRNA, showing alternative splicing of exon 14. (<bold>D</bold>) Relative expression of <italic>FMR1</italic> constitutive exons 7&#8211;8 using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of <italic>FMR2</italic> gene. No difference is observed between the two samples. (<bold>E</bold>) Relative expression of exon 14 sequence-including <italic>FMR1</italic> isoforms using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of <italic>FMR2</italic> gene. An increased expression level of 50% is observed for exon 14-containing <italic>FMR1</italic> isoforms mRNA in FRAXE fibroblasts.</p></caption><graphic xlink:href="gkn1058f6"/></fig>
###xml 2985 2992 <span type="species:ncbi:9606">patient</span>
###xml 4718 4725 <span type="species:ncbi:9606">patient</span>
###xml 4971 4978 <span type="species:ncbi:9606">patient</span>
The G-quartet being a purine-rich element, it has features of an exonic splicing enhancer (ESE), a group of discrete sequences within exons that promote both constitutive and regulated splicing (30). In particular, the G-quartet present in the FMR1 mRNA has been recently shown to be a potent ESE (15). To confirm these data, we introduced the FBS sequence into the middle exon of the SXN13 minigene (19), generating SXN/FBS and we transfected HeLa cells with one or the other minigene. The presence of a G-quartet determines the complete inclusion of exon 2 in the SXN/FBS mRNA, which was detected by semiquantitative RT-PCR using primers localized in exon 1 and 3 of the minigene (Figure 6A). Starting from this observation, we tested whether FBS/FMR2 interaction could regulate the splicing of the SXN/FBS minigene. To this purpose, we co-transfected HeLa cells with the SXN/FBS minigene and with full-length FMR2, C-ter, N-ter or the empty vector. Since differences in the expression of the SXN/FBS minigene were difficult to appreciate in non-quantitative conditions, we evaluated the relative expression of transcripts with alternative exon 2 inclusion by real-time quantitative PCR (primers are localized in exon 1 and exon junction between exon 2 and 3 of minigene. Their sequences are described in Table 3). As shown in Figure 6B, inclusion of the exon containing FBS was decreased about 2-fold in cells co-transfected with full-length FMR2 or C-ter relative to cells co-transfected with the empty vector or with the N-ter. In this experiment, the expression level of each FMR2 protein was tested by western blot and quantitative RT-PCR, as illustrated in . To exclude that this result is due to a different decay of the mRNA coding for minigene isoforms in the presence or in the absence of FMR2, we tested the stability of SXN/FBS minigene in HeLa cells transfected and treated with ActD for 6 h. No difference in decay of exon2-containing minigene mRNA was observed during this treatment in cell transfected with FMR2-pTL or the pTL empty vector (). Also in this case, the expression level of FMR2 was tested by western blot () using the monoclonal anti-Flag antibody. This finding suggests that the FBS/FMR2 interaction modulates and influences the splicing efficiency of a minigene containing FBS and that this function is retained by the C-ter, but not by the N-ter domain, which does not bind to the FBS. These data suggest that inclusion of a G-quartet-containing exon in a mature mRNA might be modulated in vivo by FMR2. We asked whether the absence of FMR2 has an impact on the alternative splicing pattern of the FMR1 gene, containing a G-quartet structure in its exon 15 near to the 3' acceptor sites necessary for alternative splicing of exon 14 (16). This structure is a potent exonic splicing enhancer [(15) and this study]. For this reason, we tested the expression level of exon 14-containing FMR1 isoforms in normal fibroblasts and in a cell line of a FRAXE patient carrying a deletion of FMR2, that completely abolishes the expression of this gene (1). For this quantification, we used real-time PCR using different sets of primers: a couple of primers amplifying the N-terminal region of FMR1 mRNA (exons 7 and 8) and a couple of primers located in exon 13 and exon 14 (Figure 6C), giving the possibility to evaluate the inclusion of the exon 14 sequence in the FMR1 mature mRNA. Interestingly, the overall expression of FMR1 (all isoforms) is not influenced by the absence of FMR2 (Figure 6D), while in FRAXE fibroblasts the inclusion of exon 14 in FMR1 mRNA is increased of 50% when compared with normal fibroblasts (Figure 6E). This demonstrated altered inclusion of exon 14 in the mature mRNA of FMR1 in the absence of FMR2. Figure 6.Effect of FMR2 on splicing of an alternative exon in minigene-transfected cells and in the endogenous FMR1 transcript. (A) Schematic representation of SXN13 minigene and of SXN13/FBS minigene. This last one includes G-quartet in exon 2. Visualization of splicing products of the minigene by semiquantitative RT-PCR. Black arrows indicate primers positions. (B) Relative expression of the inclusion of minigene exon 2 using real-time quantitative PCR in the presence or in the absence of FMR2, C-ter and N-ter proteins. Results were obtained by analysis of three independent transfection experiments. Red arrows indicate primers postitions, GAPDH was used as a standard. Error bars represent standard deviation. (C) Schematic structure of the FMR1 full-length mRNA, showing alternative splicing of exon 14. (D) Relative expression of FMR1 constitutive exons 7-8 using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of FMR2 gene. No difference is observed between the two samples. (E) Relative expression of exon 14 sequence-including FMR1 isoforms using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of FMR2 gene. An increased expression level of 50% is observed for exon 14-containing FMR1 isoforms mRNA in FRAXE fibroblasts.
###end p 45
###begin p 46
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 120 121 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 358 359 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 712 713 712 713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 742 746 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 807 808 807 808 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 833 837 833 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 984 988 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 1047 1048 1047 1048 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1100 1104 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 1237 1241 1237 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 1320 1324 1320 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 951 958 <span type="species:ncbi:9606">patient</span>
###xml 1204 1211 <span type="species:ncbi:9606">patient</span>
Effect of FMR2 on splicing of an alternative exon in minigene-transfected cells and in the endogenous FMR1 transcript. (A) Schematic representation of SXN13 minigene and of SXN13/FBS minigene. This last one includes G-quartet in exon 2. Visualization of splicing products of the minigene by semiquantitative RT-PCR. Black arrows indicate primers positions. (B) Relative expression of the inclusion of minigene exon 2 using real-time quantitative PCR in the presence or in the absence of FMR2, C-ter and N-ter proteins. Results were obtained by analysis of three independent transfection experiments. Red arrows indicate primers postitions, GAPDH was used as a standard. Error bars represent standard deviation. (C) Schematic structure of the FMR1 full-length mRNA, showing alternative splicing of exon 14. (D) Relative expression of FMR1 constitutive exons 7-8 using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of FMR2 gene. No difference is observed between the two samples. (E) Relative expression of exon 14 sequence-including FMR1 isoforms using real-time quantitative PCR in normal fibroblasts and in fibroblasts obtained from a patient carrying the deletion of FMR2 gene. An increased expression level of 50% is observed for exon 14-containing FMR1 isoforms mRNA in FRAXE fibroblasts.
###end p 46
###begin title 47
DISCUSSION
###end title 47
###begin p 48
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1234 1236 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1300 1302 1300 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1473 1475 1473 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2070 2072 2070 2072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2296 2298 2296 2298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 2751 2753 2751 2753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 3305 3309 3305 3309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3343 3347 3343 3347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR2</italic>
###xml 3419 3423 3419 3423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3499 3503 3499 3503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 3608 3610 3608 3610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 3611 3613 3611 3613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 3691 3695 3691 3695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
FMR2 expression is silenced in FRAXE mental retardation and its precise function is not known. Previous studies have been suggested that FMR2 function is related to transcriptional regulation in the nucleus. This assumption was based on the observation that FMR2 was exclusively detected in the nuclear compartment and that short N-terminal fragments of the protein have been reported to act as transcriptional activators of the adenovirus E1b minimal promoter (14). This function was also supported by analogy and homology with AF4, a member of the same gene family, that has been reported to interact with PolII transcription elongation factor b (P-TEFb) kinase and in complex with AF9, ENL and AF10 mediates methylation of histone H3-K79 (11). Our study reveals an additional important function of FMR2, providing a novel insight on the molecular basis of FRAXE mental retardation by providing evidence that FMR2 is an RNA binding protein having a putative role in the regulation of splicing of the G-quartet structure-containing mRNA. We show here that FMR2 has high affinity for RNA and, in particular, we demonstrate its specificity towards G-quartet RNA. G-quartet RNA motifs are known to play a role in translational control (17,31) and in controlling splicing efficiency working as an ESE [(15) and this study]. We show that FMR2 is co-localized with SC35 in the nuclear speckle domains, the compartments where splicing factors are stored, assembled and modified (25). Interestingly, blocking pre-mRNA splicing induces the redistribution of a subpopulation of FMR2 molecules in nuclear speckles containing the SC35 splicing factor, while another pool of the protein accumulates in the nucleolus. This observation suggests that FMR2 shuttles between speckles and splicing sites, where it can pick up cargo RNAs and transfer them to the nucleolus where they can undergo subsequent modifications. Indeed, the nucleolus performs additional roles beyond generating ribosomal subunits, since about 5% of nucleolar components are proteins involved in mRNA processing (32). Intriguingly, the ability of the herpes virus saimiri ORF57 protein to export of virus mRNA to the cytoplasm is dependent on its nucleolar localization, suggesting a critical role of the nucleolus in mRNA export process (33). On the other hand, blocking transcription by ActD treatment determines FMR2 localization within enlarged nuclear speckles-like structure and also its accumulation in the cytoplasm. Indeed, it is known that inhibition of PolII transcription by actinomycin D induces the accumulation of some RNA-binding proteins and transcription factors in the cytoplasm (e.g. hnRNP A1 protein) where they are confined when no exported RNA is synthetized in nucleus (34). Taken together, our data suggest a possible role of FMR2 in post-transcriptional modifications of RNA and, in particular, in splicing. We validated this hypothesis using a model minigene system which allowed us to demonstrate that the over-expression of FMR2 has an impact on the inclusion of the alternative exon 2 containing the G-quartet structure bound by FMR2 in the mature RNA. Indeed, we show here that the presence of FMR2 does not influence the stability of the minigene mRNA. Moreover, we tested the expression level of exon-14 containing FMR1 isoforms in fibroblasts null for FMR2. The interest to study these splicing variants is due to the fact that FMR1 exon 14 encodes a nuclear export signal (NES) sequence. Exon 14-containing FMR1 isoforms display cytoplasmic localization, while exon 14-lacking isoforms are localized in the nucleus (16,35). Interestingly, the absence of FMR2 does not affect the total expression of FMR1 mRNA but increases the expression of the isoforms containing exon 14 and encoding a protein localized in the cytoplasm.
###end p 48
###begin p 49
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 973 975 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1066 1068 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
The role of FMR2 in splicing is not exclusive to its role in transcriptional regulation, since we cannot exclude that the function of FMR2 is modulated by the interaction with transcription factors, as, shown, for example, for SWI/SNF, a complex involved both in chromatin remodelling and regulation of alternative splicing (36). Remarkably, the N-terminal region of FMR2 is able to affect transcription (14), while we show here that its C-terminal domain modulates splicing. Furthermore, one of the proteins belonging to the same family as FMR2, AF4, has been shown to stimulate RNA polymerase II transcriptional elongation and mediate coordinated chromatin remodeling (11). We can also add that the role of transciption factor in post-transcription RNA metabolism is more and more evident, as, for example, recently reported (37). Indeed, these authors have shown the molecular mechanism by which RA/RARalpha regulates translation of specific mRNA in neuronal dendrites (37). Even the orphan nuclear receptor DAX-1 was shown to have a role in the mRNA metabolism (38).
###end p 49
###begin p 50
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR</italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
Our data indicate a role of FMR2 in splicing of FMR1 pre-mRNA. This suggests that alteration of FMRP expression in FRAXE patients may participate in the physiopathology of this syndrome. The partial effect of FMR2 on FMR1 exon14 inclusion may be due to partial rescue of FMR2 function by its homologous proteins, which are expressed in a broad range of tissues, as also recently described for RBM5 and its homologues RBM6 and RBM10 (39). Alternatively, it is worth to underline that probably other RNA-binding proteins control the complex splicing pattern of FMR1 with a different impact in different tissues, as shown for NMDA receptor 1 (NR1). The inclusion of exon 19 into mature NR1 mRNA is in fact regulated by the balanced action of several RNA-binding proteins: hnRNP A1, hnRNP H, Nova and NAPOR (40).
###end p 50
###begin p 51
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 220 230 220 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1, ATRX</italic>
###xml 232 244 232 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuroligin 3</italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 409 421 409 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuroligin 3</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
A long list of RNAs exists containing putative G-quartet structures that are located in the proximity of an alternatively spliced site () (41). Subtle alterations of the alternative splicing of some of these genes (e.g. FMR1, ATRX, Neuroligin 3, etc.) in the absence of FMR2 may then be relevant to the pathogenesis of the FRAXE syndrome. Indeed, mutations in ATRX cause a form of mental retardation (42) and Neuroligin 3 has been shown to be implicated in autism (43), a phenotype also described in FRAXE patients (4).
###end p 51
###begin p 52
In conclusion, here we have described a novel function FMR2 in splicing. While further analysis will be necessary to completely identify all the FMR2 targets mRNAs and its precise mechanism of action, our data show that FMR2 is a multifunctional protein linking RNA metabolism and transcriptional control.
###end p 52
###begin title 53
SUPPLEMENTARY DATA
###end title 53
###begin p 54
 are available at NAR Online.
###end p 54
###begin title 55
FUNDING
###end title 55
###begin p 56
CNRS, INSERM, GIS-Maladies Rares, ANR (to B.B.); AFM (to B.B. and E.L.); INCa and Conseil General Alpes-Maritimes (to E.L.); Italian Telethon (to M.V.C.); Fondation Telecom Autisme (to M.B. partial); PhD fellowship by 'La Ligue Contre le Cancer' (to M.M.); 'Fondation pour la Recherche Medicale' (to M.M.); Boerhinger Ingelheim Fund (to M.M.); intraeuropean fellowship from the Marie Curie 6th Framework Program (to L.D.). Funding for open access charge: Agence Nationale de la Recherche (ANR-06-NEURO-015-01).
###end p 56
###begin p 57
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 57
###begin title 58
Supplementary Material
###end title 58
###begin title 59
[Supplementary Data]
###end title 59
###begin title 60
ACKNOWLEDGEMENTS
###end title 60
###begin p 61
We thank Tom Cooper, Herve Moine, David Nelson, Francoise Presse, Celine Verheggen and Jasper Saris for gift of material, Josiane Grosgeorge and Frederic Brau for excellent technical assistance.
###end p 61
###begin title 62
REFERENCES
###end title 62
###begin article-title 63
Identification of the gene FMR2, associated with FRAXE mental retardation
###end article-title 63
###begin article-title 64
Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island
###end article-title 64
###begin article-title 65
Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation
###end article-title 65
###begin article-title 66
###xml 76 84 <span type="species:ncbi:9606">children</span>
Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE
###end article-title 66
###begin article-title 67
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice
###end article-title 67
###begin article-title 68
Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators
###end article-title 68
###begin article-title 69
Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain
###end article-title 69
###begin article-title 70
A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias
###end article-title 70
###begin article-title 71
LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias
###end article-title 71
###begin article-title 72
###xml 64 70 <span type="species:ncbi:9606">infant</span>
AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)
###end article-title 72
###begin article-title 73
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling
###end article-title 73
###begin article-title 74
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Altered lymphoid development in mice deficient for the mAF4 proto-oncogene
###end article-title 74
###begin article-title 75
Transcriptional regulation of cytoskeletal functions and segmentation by a novel maternal pair-rule gene, lilliputian
###end article-title 75
###begin article-title 76
Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator
###end article-title 76
###begin article-title 77
The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer
###end article-title 77
###begin article-title 78
Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms
###end article-title 78
###begin article-title 79
###xml 82 88 <span type="species:ncbi:10090">murine</span>
FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts
###end article-title 79
###begin article-title 80
The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif
###end article-title 80
###begin article-title 81
Identification of a new class of exonic splicing enhancers by in vivo selection
###end article-title 81
###begin article-title 82
A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein
###end article-title 82
###begin article-title 83
A direct role of SRY and SOX proteins in pre-mRNA splicing
###end article-title 83
###begin article-title 84
Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure
###end article-title 84
###begin article-title 85
###xml 138 146 <span type="species:ncbi:9606">patients</span>
Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients
###end article-title 85
###begin article-title 86
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 86
###begin article-title 87
Nuclear speckles: a model for nuclear organelles
###end article-title 87
###begin article-title 88
Disruption of pre-mRNA in vivo results in reorganization of splicing factors
###end article-title 88
###begin article-title 89
RNABindR:a server for analyzing and predicting RNA-binding sites proteins
###end article-title 89
###begin article-title 90
Interactions of the G-quartet forming semaphorin 3F RNA with the RGG box domain of the fragile X protein family
###end article-title 90
###begin article-title 91
Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops
###end article-title 91
###begin article-title 92
###xml 70 75 <span type="species:ncbi:9606">human</span>
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
###end article-title 92
###begin article-title 93
An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation
###end article-title 93
###begin article-title 94
The nucleolus
###end article-title 94
###begin article-title 95
Nucleolar trafficking is essential for nuclear export of intronless herpesvirus mRNA
###end article-title 95
###begin article-title 96
Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm
###end article-title 96
###begin article-title 97
Analysis of domains affecting intracellular localization of the FMRP protein
###end article-title 97
###begin article-title 98
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human SWI/SNF subunit Brm is a regulator of alternative splicing
###end article-title 98
###begin article-title 99
Retinoic acid-gated sequence-specific translational control by RARalpha
###end article-title 99
###begin article-title 100
Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA
###end article-title 100
###begin article-title 101
RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition
###end article-title 101
###begin article-title 102
RNA binding proteins and the regulation of neuronal synaptic plasticity
###end article-title 102
###begin article-title 103
GRSDB2 and GRS_UTRdb: databases of quadruplex formi,g G-rich sequences in pre-mRNA and mRNAs
###end article-title 103
###begin article-title 104
A novel mutation in the putative DNA helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome
###end article-title 104
###begin article-title 105
###xml 91 95 <span type="species:ncbi:10090">mice</span>
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice
###end article-title 105

